Coronavirus vaccine. Sanofi: Americans first. Annoyed Macron

Fedaisf editorial staff

May 14, 2020

Sanofi, the French pharmaceutical company, has come under fire after the leak of news about the agreements with America. He stressed that the vaccines will also go to Europe, if it is equally effective in funding vaccine studies. “In this period the Americans are effective – explained the President of Sanofi France, Olivier Bogillot, reports Adnkronos. “The EU must also be the same, helping us to make the vaccine available very quickly ". continued the manager revealing that America has already planned to pay hundreds of thousands of euros, while with the European authorities it is still at the level of "pourparler". Eventually however, he concluded that there will be enough doses for everyone. The differences will mainly concern the timing of administration.

The French prime minister also intervened today on the case Edouard Philippe: “Equal access for all to the vaccine is not negotiable”. Philippe, who today spoke with the chairman of the board of directors of Sanofi, Serge Weinberg. The latter, he had written shortly before in a tweet, “has provided me with all the necessary reassurances regarding the distribution in France of a possible Sanofi vaccine“. Even the French president Emmanuel Macron he is "annoyed" by the announcement of the CEO of Sanofi. Macron is pushing for vaccines to be considered a "common good" for humanity that should not be subject to market pressures. Next week there will be a meeting with Sanofi in Macron's office.

Meanwhile, it is expected that the last of the vaccinated could be immunized even several years after the first. To the 12-18 months needed to develop a definitive remedy against the pandemic, the times for production and distribution should also be added. Of the 110 groups at work around the world, each with a different technical approach, about a third are in the USA, about fifteen in Europe and the same number in China. Whoever gets immunization sooner will be able to reopen his economy. Beijing is in the lead, with four of the eight prototypes already being tested on humans and positive data in monkeys.

Source: Adnkronos, Repubblica, La Stampa, Il Fatto Quotidiano, Dire